S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage
- 1 November 1989
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 71 (5), 727-731
- https://doi.org/10.3171/jns.1989.71.5.0727
Abstract
Cerebrospinal fluid (CSF) markers of brain damage are potentially capable of providing quantitative information about the extent of certain neurological injury. The presence of such markers in CSF after brain damage is transient and it is essential to understand their kinetics if they are to be used in clinical practice. In the present study, the CSF concentrations of two neurospecific proteins. S-100 protein and neuron-specific enolase (NSE), were determined in rats before and repeatedly after one of two types of experimental brain damage: traumatic cortical injury and focal cerebral ischemia induced by middle cerebral artery (MCA) occlusion. The two types of experimental brain damage resulted in significant differences in the kinetics of S-100 and NSE concentrations in CSF. Cortical contusion was followed by a rapid increase in both S-100 and NSE and a peak occurred in both after about 7 1/2 hours, at which time the values declined toward normal. A second, smaller peak was seen after about 1 1/2 days. The increase and decrease in S-100 and NSE levels in CSF was slower after MCA occlusion; a peak was seen after 2 to 4 days. Furthermore, S-100 was generally higher than NSE after trauma, whereas after MCA occlusion the NSE concentration was slightly higher than the S-100 value. These results support the use of CSF markers for estimation of the extent of brain damage in experimental models and forms a basis for the understanding of their kinetics, which is important for their use in clinical practice.This publication has 23 references indexed in Scilit:
- Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats.Stroke, 1989
- Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid.Stroke, 1988
- S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.Stroke, 1987
- S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhageJournal of Neurosurgery, 1985
- Cerebrospinal fluid enolase in stroke.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- Temporal profile of neuronal damage in a model of transient forebrain ischemiaAnnals of Neurology, 1982
- Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological changeJournal of Neurology, Neurosurgery & Psychiatry, 1981
- MEASUREMENT OF NEURON‐SPECIFIC (NSE) AND NON‐NEURONAL (NNE) ISOENZYMES OF ENOLASE IN RAT, MONKEY AND HUMAN NERVOUS TISSUEJournal of Neurochemistry, 1979
- Cerebrospinal fluid enzymes in acute brain injury. 1. Dynamics of changes in CSF enzyme activity after acute experimental brain injury.Journal of Neurology, Neurosurgery & Psychiatry, 1977